6-Chloro-2,3-dihydro-1H-pyrido[2,3-b][1,4]oxazine, 97%, 100mg

Di-?-chlorobis[2'-(amino-N)[1,1'-biphenyl]-2-yl-C]dipalladium(II), 98%, 1g

3-chloro-5-methoxy-4-propoxybenzonitrile, 100mg

7-BROMO-4,5-DIHYDRO-1H-BENZO[B]AZEPIN-2(3H)-ONE, 95%, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylbutanoic acid, 95.0%, 1g

4-(4-Bromophenyl)pyridine, 95.0%, 10g

2,6-Di-tert-butylcyclohexa-2,5-diene-1,4-dione, 99.00%, 1g

Tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 98%, 5g

5-(3-Fluoro-benzyl)-3-phenyl-[1,2,4]oxadiazole, 95.0%, 1g

GC-Kapillarsäule ROTI®Cap-5, unpolar, L 15 m, Ø-Innen 0,53 mm, Filmd. 0,50 µm, 1 Stück

(2-((Diphenylphosphino)methyl)-2-methylpropane-1,3-diyl)bis(diphenylphosphine), 98%, 25g

4-(Bromomethyl)benzamide, 90.0%, 100mg

2-Chloro-N-[5-(dimethylamino)-2-nitrophenyl]-5-nitrobenzamide, 95.0%, 1g